Business, energy, technology, markets and global industry news from Business News Today

DexCom

PharmaDeviceNews DexCom
Insulet’s Omnipod 5 launch in Spain expands access to tubeless automated insulin delivery, continuous glucose monitoring and connected diabetes technology. Representative image.
Medical Devices & Diagnostics

Can Insulet’s new diabetes data platform improve time in range and patient engagement?

Insulet launches Omnipod Discover across the US after 15,000 users adopt the platform. Examine its glucose data, clinical evidence and impact.

Read More
FDA-cleared over-the-counter continuous glucose sensors are expanding glucose monitoring beyond insulin users, but evidence for meaningful weight loss or broad metabolic benefits in people without diabetes remains limited. Representative image.
Medical Devices & Diagnostics

Could a sensor 10 times shorter challenge Dexcom and Abbott? Ascensia is betting on Sava

Ascensia backs Sava's $36M glucose microsensor push, but clinical validation and CE marking remain critical before its planned European launch.

Read More
Representative image: A continuous glucose monitoring sensor and smartphone glucose trend display illustrate how Dexcom G7 could expand CGM use for adults with type 2 diabetes not using insulin after the CONNECT study.
Medical Devices & Diagnostics

Can Dexcom G7 reshape CGM adoption for type 2 diabetes patients not using insulin?

Find out how Dexcom G7 data could reshape CGM adoption for type 2 diabetes patients not using insulin.

Read More